Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Prospective Validation of the ROL System in Substaging Pt1 High-Grade Bladder Cancer: Results from a Prospective Mono-Institutional Confirmatory Analysis in BCG Treated Patients

Version 1 : Received: 5 January 2023 / Approved: 9 January 2023 / Online: 9 January 2023 (01:17:29 CET)

A peer-reviewed article of this Preprint also exists.

Valeri, M.; Contieri, R.; Fasulo, V.; Iuzzolino, M.; Cieri, M.; Elefante, G.M.; De Carlo, C.; Bressan, A.; Saitta, C.; Gobbo, A.; Avolio, P.P.; Dacrema, V.; Lazzeri, M.; Taverna, G.; Terracciano, L.M.; Hurle, R.; Colombo, P. Prospective Validation of the ROL System in Substaging pT1 High-Grade Urothelial Carcinoma: Results from a Mono-Institutional Confirmatory Analysis in BCG Treated Patients. Cancers 2023, 15, 934. Valeri, M.; Contieri, R.; Fasulo, V.; Iuzzolino, M.; Cieri, M.; Elefante, G.M.; De Carlo, C.; Bressan, A.; Saitta, C.; Gobbo, A.; Avolio, P.P.; Dacrema, V.; Lazzeri, M.; Taverna, G.; Terracciano, L.M.; Hurle, R.; Colombo, P. Prospective Validation of the ROL System in Substaging pT1 High-Grade Urothelial Carcinoma: Results from a Mono-Institutional Confirmatory Analysis in BCG Treated Patients. Cancers 2023, 15, 934.

Abstract

Patients with pT1 high-grade (HG) bladder cancer (BC) and a very high risk of progression might benefit from immediate radical cystectomy (RC), but this option remains controversial. Validation of a standardized method to evaluate the extent of lamina propria (LP) invasion (with recognized prognostic value) in transurethral resections (TURBT) specimens is still needed. The Rete Oncologica Lombarda (ROL) system showed a high predictive value for progression after TURBT in recent retrospective studies. Our aim was to validate ROL system on a large mono-institutional prospective series of primary urothelial carcinomas. From 2016 to 2020, we adopted ROL for all patients with pT1 HG BC on TURBT. We employed a 1.0-mm threshold to stratify tumors in ROL1 and ROL2. A total of 222 pT1HGBC were analyzed. Median age was 74 years, with male predominance (73.8%). ROL was feasible in all cases: 91 cases were ROL1 (41%) and 131 ROL2 (59%). At a median follow up of 26.9 months (IQR 13.8-40.6), we registered 80 recurrences and 40 progressions. ROL was a significant predictor of tumor progression at both univariable (HR 3.53; CI 95% 1.56 – 7.99; p<0.01) and multivariable (HR 2.90; CI 95% 1.25 – 6.75; p=0.01) Cox regression analyses. At Kaplan-Meier estimates, ROL showed correlation with both PFS (p=0.0012) and RFS (p=0.0167). Our results confirmed the strong predictive value of ROL for progression on a large prospective series. We encourage the application of ROL for reporting the extent of LP invasion, substaging T1 HG BC, and improving risk tables for urological decision making.

Keywords

BCG; bladder cancer; non-muscle-invasive bladder cancer; prospective validation; pT1 high-grade bladder cancer; risk stratification; ROL; substaging; TURBT; urothelial carcinoma.

Subject

Medicine and Pharmacology, Pathology and Pathobiology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.